| CA-19-9, Gastric & Pancreatic Cancer, ELISA Kit
| CA-19-9, Gastric & Pancreatic Cancer, ELISA Kit
|
| CA-19-9 Gastrointestinal Tumor Assoc Marker 19-9, Sialyl Lacto-N-fucopentose, Lewis A, Cl: B46,Mab anti-Hu,frozen/paraffin
| CA-19-9 Gastrointestinal Tumor Assoc Marker 19-9, Sialyl Lacto-N-fucopentose, Lewis A, Cl: B46,Mab anti-Hu,frozen/paraffin
|
| CA242 (GASTROINTESTINAL CANCER) | CA242 (GASTROINTESTINAL CANCER) |
| CagA(Standard Range: 0-240 RU/ml //sensit. vs Western Blot: 93.7 %)
| CagA(Standard Range: 0-240 RU/ml //sensit. vs Western Blot: 93.7 )
|
| CAGCCATGGCTG, 5'-NON-PHOSPHORYLATED | CAGCCATGGCTG, 5'-NON-PHOSPHORYLATED |
| CAGCCATGGCTG, 5'-PHOSPHORYLATED | CAGCCATGGCTG, 5'-PHOSPHORYLATED |
| CAEVM protocol | CAEVM protocol |
| CAFLVKEVTKLIDNNKTEKEIL | CAFLVKEVTKLIDNNKTEKEIL |
| C3a [Fmoc-Glu70, Ala71,72, Lys74] (70-77) [Fmoc-Glu-Ala-Ala-Leu-Lys-Leu-Ala-Arg]
| C3a [Fmoc-Glu70, Ala71,72, Lys74] (70-77) [Fmoc-Glu-Ala-Ala-Leu-Lys-Leu-Ala-Arg]
|
| 141911-75-3 | CAf1M protein | CAf1M protein |
| 154026-67-2 | CAGED CA2+ CHANNEL ANTAGONIST | CAGED CA2+ CHANNEL ANTAGONIST |
| caged FEDA-ATP | caged FEDA-ATP |
| caged sphingosine 1-phosphate | caged sphingosine 1-phosphate |
| caged isocitrate | caged isocitrate |
| 125455-57-4 | 'CAGED GTP | 'CAGED GTP |
| CAGED GLUTAMIC ACID | CAGED GLUTAMIC ACID |
| CAGED GABA | CAGED GABA |
| CAGED ASPARTIC ACID, SODIUM SALT | CAGED ASPARTIC ACID, SODIUM SALT |
| CAGED CGMP | CAGED CGMP |
| Caged Glutamic Acid, Sodium Salt | Caged Glutamic Acid, Sodium Salt |
| Caged GTP, Dimethoxy-, Trisodium Salt | Caged GTP, Dimethoxy-, Trisodium Salt |
| Caged GABA, Sodium Salt | Caged GABA, Sodium Salt |
| Caged Ins(1,4,5)P3, L pack
| Caged Ins(1,4,5)P3, L pack
|
| Caged Ins(1,4,5)P3, S pack
| Caged Ins(1,4,5)P3, S pack
|
| CAGED FLUORESCEIN
| CAGED FLUORESCEIN
|
| CAGED FLUORESCEIN SULFO-OSU
| CAGED FLUORESCEIN SULFO-OSU
|
| CAGED INS(1,4,5)P3, TRISODIUM SALT | CAGED INS(1,4,5)P3, TRISODIUM SALT |
| 171800-68-3 | CAGED ATP, DISODIUM SALT | CAGED ATP, DISODIUM SALT |
| 207516-11-8 | CAGED D-ERYTHRO-SPHINGOSINE-1-PHOSPHATE | CAGED D-ERYTHRO-SPHINGOSINE-1-PHOSPHATE |
| CAGED FLUORESCEIN MALEIMIDE | CAGED FLUORESCEIN MALEIMIDE |
| 36885-29-7 | ビス(6,6,7,7,8,8,8-ヘプタフルオロ-2,2-ジメチル-3,5-オクタンジオナト)カルシウム | CA(FOD)2 |
| 167776-24-1 | CAGED FLUORESCEIN MALEIMIDE* | CAGED FLUORESCEIN MALEIMIDE* |
| caged AIP | caged AIP |
| CAGEDFULLERENEDERIVATIVE | CAGEDFULLERENEDERIVATIVE |
| caged cyclic ADP-ribose | caged cyclic ADP-ribose |
| caged nuclear localization signal | caged nuclear localization signal |
| CA150, exon 1 (Transcription Factor CA150, TCERG1, Transcription Elongation Regulator 1, TAF2S, TATA Box-Binding Protein-Associated Factor 2S)
| CA150, exon 1 (Transcription Factor CA150, TCERG1, Transcription Elongation Regulator 1, TAF2S, TATA Box-Binding Protein-Associated Factor 2S)
|
| CAGDOWN PRIMER | CAGDOWN PRIMER |
| Cage for Fused Silica Column | Cage for Fused Silica Column |
| CAGDRLTGIPSHILNSSPSD | CAGDRLTGIPSHILNSSPSD |
| cager-2 protein | cager-2 protein |
| CAF-PH protocol | CAF-PH protocol |
| cager-1 protein | cager-1 protein |
| 5' CAG GAA ACA GCT ATG ACC 3' | 5' CAG GAA ACA GCT ATG ACC 3' |
| CAGGCGCCTG, 5'-NON-PHOSPHORYLATED | CAGGCGCCTG, 5'-NON-PHOSPHORYLATED |
| CAGGCGCCTG, 5'-PHOSPHORYLATED | CAGGCGCCTG, 5'-PHOSPHORYLATED |
| CAF-1 protein, Drosophila | CAF-1 protein, Drosophila |
| caf1 protein, Yersinia pestis | caf1 protein, Yersinia pestis |
| CAF protocol 2 | CAF protocol 2 |
| CAF protocol | CAF protocol |
| CA 19-9 (GI Cancer Marker Test)
| CA 19-9 (GI Cancer Marker Test)
|
| CAFRQVCHTTVPWPNASLTP | CAFRQVCHTTVPWPNASLTP |
| 67879-58-7 | (2R,3R)-2-[[(E)-3-(3,4-ジヒドロキシフェニル)-1-オキソ-2-プロペニル]オキシ]-3-ヒドロキシブタン二酸 | CAFTARIC ACID |
| CAFTARIC ACID(AHP) | CAFTARIC ACID(AHP) |
| (2R,3R)-2-[[(E)-3-(3,4-ジオキソ-1,5-シクロヘキサジエン-1-イル)-1-オキソ-2-プロペニル]オキシ]-3-ヒドロキシブタン二酸 | Caftaric acid o-quinone |
| CAFVP protocol | CAFVP protocol |
| CA549 glycoprotein | CA549 glycoprotein |
| 51732-61-7 | 7C-aglycone | 7C-aglycone |
| 34927-45-2 | 5C-aglycone | 5C-aglycone |
| CA GLYCEROPHOSPHATE | CA GLYCEROPHOSPHATE |
| 115774-57-7 | cagocel-1 | cagocel-1 |
| 147387-25-5 | CAG1 protein | CAG1 protein |
| CAG protocol | CAG protocol |
| CAG7 protein | CAG7 protein |
| CAG Repeat Length Mutation in Huntington's Disease | CAG Repeat Length Mutation in Huntington's Disease |
| 869376-90-9 | CB-52 | CB-52 |
| 1150586-64-3 | CB-86 | CB-86 |
| 1391054-76-4 | CB 80 | CB 80 |
| 289715-28-2 | CB 300919 | CB 300919 |
| 165307-47-1 | (1R,5R,8E)-5-(3-ヒドロキシフェニル)-2-メチル-8-(3,4-ジクロロベンジリデン)-2-アザビシクロ[3.3.1]ノナン-7-オン | CB 184 |
| 206275-15-2 | N-(3-ピリジニルメチル)-4-[プロパルギル[(2-メチル-4-オキソ-7-ブロモ-3,4-ジヒドロキナゾリン-6-イル)メチル]アミノ]ベンズアミド | CB 30865 |
| 6,8-ジクロロ-2-(4-クロロフェニル)-N,N-ジプロピルイミダゾ[1,2-a]ピリジン-3-アセトアミド | CB 34 |
| CB | CB |
| 59454-35-2 | 4'-デシル-1,1'-ビフェニル-4-カルボニトリル | 10CB |
| CB101 | CB101 |
| CB28 | CB28 |
| CB 54 | CB 54 |
| 128312-71-0 | (20S)-1α,26-ジヒドロキシ-25-デメチル-26,26-ジエチルコレカルシフェロール | CB 966 |
| (1S,5S,8E)-5-(3-ヒドロキシフェニル)-2-メチル-8-(3,4-ジクロロベンジリデン)-2-アザビシクロ[3.3.1]ノナン-7-オン | CB 182 |
| 32808-58-5 | CB 848 | CB 848 |
| 32780-41-9 | CB 844 | CB 844 |
| CB105 | CB105 |
| 193979-75-8 | CB 34 | CB 34 |
| 869376-63-6 | CB-25 | CB-25 |
| 432047-72-8 | (1-ナフチル)[4-(ペンチルオキシ)-1-ナフチル]ケトン | CB 13 |
| CAGR1 protein | CAGR1 protein |
| CaiA protein | CaiA protein |
| CAGUP PRIMER | CAGUP PRIMER |
| 24739-08-0 | (14β)-C(14a)-ホモ-27-ノルガンマセラン-3α-オール | C(14a)-Homo-27-nor-14beta-gammaceran-3alpha-ol |
| C(14A)-HOMO-27-NORGCERA-13,15,17-TRIENE-3B,15,21A-TRIOL3,21-DIACETATE | C(14A)-HOMO-27-NORGCERA-13,15,17-TRIENE-3B,15,21A-TRIOL3,21-DIACETATE |
| C(14A)-HOMO-27-NORGCER-14-ENE-3B,21A-DIOL21-ACETATE3-(3-(3,4-DIACETOXYPHENYL)PROPIONATE) | C(14A)-HOMO-27-NORGCER-14-ENE-3B,21A-DIOL21-ACETATE3-(3-(3,4-DIACETOXYPHENYL)PROPIONATE) |
| C(14A)-HOMO-27-NOR-3B,14B,21A-GCERANETRIOL3,21-DIACETATE | C(14A)-HOMO-27-NOR-3B,14B,21A-GCERANETRIOL3,21-DIACETATE |
| C(14A)-HOMO-27-NORGCER-14-ENE-3B,21A-DIOL21-ACETATE3-(3-(3,4-DIMETHOXYPHENYL)PROPIONATE) | C(14A)-HOMO-27-NORGCER-14-ENE-3B,21A-DIOL21-ACETATE3-(3-(3,4-DIMETHOXYPHENYL)PROPIONATE) |
| 18070-14-9 | C(14a)-ホモ-27-ノル-5α-ガンマセラ-13-エン | C(14a)-Homo-27-nor-5α-gammacer-13-ene |
| 18188-24-4 | C(14a)-ホモ-27-ノルガンマセラン-3β,21α-ジオール | C(14a)-Homo-27-norgammacerane-3β,21α-diol |
| 25329-73-1 | セラタンI-3,21-ジオン | (14β)-C(14a)-Homo-27-norgammacerane-3,21-dione |
| 28618-19-1 | C(14a)-ホモ-27-ノルガンマセラン-3β,14β,21α-トリオール | C(14a)-Homo-27-norgammacerane-3β,14β,21α-triol |
| 1449-07-6 | α-セラタ-14-エン-3,21-ジオン | C(14a)-Homo-27-norgammacera-14-ene-3,21-dione |
| 18046-86-1 | C(14a)-ホモ-27-ノルガンマセラ-14-エン | C(14a)-Homo-27-norgammacer-14-ene |
| 77311-65-0 | C(14a)-ホモ-27-ノルガンマセラ-14-エン-3β,20β,21β,24-テトラオール | C(14a)-Homo-27-norgammacer-14-ene-3β,20β,21β,24-tetrol |